The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Downgrade knocks an effective $75 million from expected group ebit, including restructuring costs.
The Rakon board has updated shareholders on a potential takeover bid received just prior to Christmas.
ANALYSIS: Results from the Big Four banks last week were solid enough, but the market might have to wait some time for new profit records to be set.
Perfect storm of high fuel prices, low airline capacity, and significant investment in ground and air assets will serve to keep airfares in the clouds.
The retail group also confirmed online platform TheMarket’s fate.
Visitor numbers are up, along with revenues for the group and its tenants.
While there was still demand for licences, the overall result continues a declining trend.
The joint venture has invested $9.9m in US agbio startup ArkeaBio run by Kiwi expat Colin South.
The specialised workers join many others as casualties of the bank’s accelerating offshoring efforts that now span low and high-level roles across the business.